Global Health · NSE: MEDANTA · BSE: 543654
Q2 FY25 results · Jul–Sep 2024
Global Health reported revenue from operations of ₹956.55 crore (up 13.3% from Q2 FY24) and net profit of ₹130.82 crore (up 4.5% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 956.55 | 843.94 | +13.3% | 861.08 | +11.1% |
| Other income | 18.22 | 20.75 | −12.2% | 21.93 | −16.9% |
| Total income | 974.77 | 864.69 | +12.7% | 883.00 | +10.4% |
| Profit before tax | 181.10 | 170.60 | +6.2% | 143.65 | +26.1% |
| Net profit for the period | 130.82 | 125.16 | +4.5% | 106.26 | +23.1% |
| EPS, basic (₹) | 4.87 | 4.66 | +4.5% | 3.96 | +23.0% |
| Net margin (%) | 13.7 | 14.8 | 12.3 |
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 664.61 | 580.15 | +14.6% | 611.45 | +8.7% |
| Other income | 23.58 | 26.24 | −10.1% | 26.70 | −11.7% |
| Total income | 688.18 | 606.38 | +13.5% | 638.15 | +7.8% |
| Profit before tax | 143.61 | 126.89 | +13.2% | 129.74 | +10.7% |
| Net profit for the period | 104.47 | 95.10 | +9.9% | 96.28 | +8.5% |
| EPS, basic (₹) | 3.89 | 3.54 | +9.9% | 3.58 | +8.7% |
| Net margin (%) | 15.7 | 16.4 | 15.7 |
Consolidated
- Filed with BSE
- 14 Nov 2024, 16:43 IST
- Board meeting
- 14 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 14 Nov 2024, 16:43 IST
- Board meeting
- 14 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE